Social networks
21 1,159Activities
Technologies
Entity types
Location
1919 Rte de Mende, 34000 Montpellier, France
Montpellier
France
Employees
Scale: 2-10
Estimated: 7
SIREN
853071215Engaged corporates
2Added in Motherbase
3 years, 5 months agoFROM DISCOVERY TO THERAPEUTICS
MT-act is a CNRS spin-off. #techtransfer
We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them.
We developed a technology platform to charter an entirely neglected pharmaceutical space.
MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired.
Drug development, Microtubules, Tubulin code, Preclinical, Drug screening, first-in-class, and drug discovery
FROM DISCOVERY TO THERAPEUTICS
MT-act is a CNRS spin-off. #techtransfer
We develop class compounds to treat human pathologies that share a common molecular defect; dysfunction of the skeleton of the cells called microtubules - abbreviated MT. Stiffening of the skeleton of our cells is a central disease driver. That is why we act on them.
We developed a technology platform to charter an entirely neglected pharmaceutical space.
MT-act prioritizes indications based on scientific evidence, proven unmet medical needs and where the roadmap to patients is feasible and desired.
MT-act is a preclinical stage spin-off company of the CNRS (The French National Centre for Scientific Research) and the University of Montpellier
Corporate | Type | Tweets | Articles | |
---|---|---|---|---|
CNRS Innovation Research, Research Services | CNRS Innovation Research, Research Services | Other 19 Dec 2023 | | |
CNRS Research, Research Services | CNRS Research, Research Services | Other 15 Dec 2023 | |